Vargaftig BB - Search Results

1

Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha.

Faili A, Randon J, Vargaftig BB, Hatmi M. Faili A, et al. Among authors: vargaftig bb. Biochem Pharmacol. 1993 May 5;45(9):1815-20. doi: 10.1016/0006-2952(93)90438-3. Biochem Pharmacol. 1993. PMID: 8388209

2

Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics.

Hatmi M, Haye B, Gavaret JM, Vargaftig BB, Jacquemin C. Hatmi M, et al. Among authors: vargaftig bb. Br J Pharmacol. 1991 Oct;104(2):554-8. doi: 10.1111/j.1476-5381.1991.tb12467.x. Br J Pharmacol. 1991. PMID: 1665743 Free PMC article.

3

Interference of eicosapentaenoic and docosahexaenoic acids with arachidonate-and U46619-induced platelet activation and desensitization.

Hatmi M, Lussiana JP, Junien JL, Burke J, Vargaftig BB. Hatmi M, et al. Among authors: vargaftig bb. Biochem Pharmacol. 1988 Feb 1;37(3):481-9. doi: 10.1016/0006-2952(88)90218-3. Biochem Pharmacol. 1988. PMID: 2827688

4

Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation.

Faili A, Emadi S, Vargaftig BB, Hatmi M. Faili A, et al. Among authors: vargaftig bb. Br J Haematol. 1994 Sep;88(1):149-55. doi: 10.1111/j.1365-2141.1994.tb04990.x. Br J Haematol. 1994. PMID: 7803237

5

Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway.

Faili A, Randon J, Francischetti IM, Vargaftig BB, Hatmi M. Faili A, et al. Among authors: vargaftig bb. Biochem J. 1994 Feb 15;298 ( Pt 1)(Pt 1):87-91. doi: 10.1042/bj2980087. Biochem J. 1994. PMID: 8129734 Free PMC article.

6

Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation.

Mounier C, Faili A, Vargaftig BB, Bon C, Hatmi M. Mounier C, et al. Among authors: vargaftig bb. Eur J Biochem. 1993 Aug 15;216(1):169-75. doi: 10.1111/j.1432-1033.1993.tb18129.x. Eur J Biochem. 1993. PMID: 8365403 Free article.

7

Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.

Mounier C, Hatmi M, Faili A, Bon C, Vargaftig BB. Mounier C, et al. Among authors: vargaftig bb. J Pharmacol Exp Ther. 1993 Mar;264(3):1460-7. J Pharmacol Exp Ther. 1993. PMID: 8450479

8

Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathway.

Hatmi M, Randon J, Faili A, Vargaftig BB. Hatmi M, et al. Among authors: vargaftig bb. Br J Haematol. 1993 Feb;83(2):270-5. doi: 10.1111/j.1365-2141.1993.tb08282.x. Br J Haematol. 1993. PMID: 8457475

9

Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages.

Hatmi M, Havet N, Vargaftig BB, Bachelet M. Hatmi M, et al. Among authors: vargaftig bb. Prostaglandins. 1992 May;43(5):457-72. doi: 10.1016/0090-6980(92)90128-g. Prostaglandins. 1992. PMID: 1374922

10

Antigen induces leucopenia in non-immunised guinea-pigs injected with platelets from actively sensitized animals.

Pretolani M, Randon J, Vargaftig BB. Pretolani M, et al. Among authors: vargaftig bb. Br J Pharmacol. 1990 May;100(1):185-9. doi: 10.1111/j.1476-5381.1990.tb12074.x. Br J Pharmacol. 1990. PMID: 2164858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters